At a Glance
Dosage
oral
| Level | MET | 1B-LSD |
|---|---|---|
| Threshold | 40 mg | 15 µg |
| Light | 60–120 mg | 25–75 µg |
| Common | 120–150 mg | 75–150 µg |
| Strong | 150–200 mg | 150–300 µg |
| Heavy | 200 mg | 300 µg |
Only in MET
insufflated
| Level | Dose |
|---|---|
| Threshold | 5 mg |
Duration
oral
MET
oral
Afterglow
Onset: 1 hrs – 2 hrsCome Up: 30 min – 1 hrsPeak: 1.5 hrs – 2.5 hrsOffset: 1 hrs – 3 hrsAfterglow: 6 hrs – 24 hrs
Total: 4 hrs – 6 hrs
1B-LSD
oral
Effects
Safety
Interaction: MET + 1B-LSD
Low Risk & Synergy
Cross-tolerance exists; effects compound
MET — Dangerous Interactions
No dangerous interactions recorded.
1B-LSD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between MET and 1B-LSD?
MET is classified as a Psychedelic (Substituted tryptamines) while 1B-LSD is classified as a Psychedelic (Lysergamides). They share 42 effects in common, with 7 effects unique to MET and 16 unique to 1B-LSD.
Is it safe to combine MET and 1B-LSD?
The interaction between MET and 1B-LSD is classified as "Low Risk & Synergy". Cross-tolerance exists; effects compound Always research interactions thoroughly before combining any substances.
Which is stronger, MET or 1B-LSD?
At common doses via oral, MET is typically dosed at 120–150 mg while 1B-LSD is dosed at 75–150 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.